Northwestern Mutual Wealth Management Co. lessened its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 3.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 116,119 shares of the exchange traded fund’s stock after selling 4,085 shares during the period. Northwestern Mutual Wealth Management Co. owned approximately 0.17% of SPDR S&P Biotech ETF worth $14,158,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in XBI. Foundations Investment Advisors LLC purchased a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at about $280,000. Huntington National Bank boosted its stake in SPDR S&P Biotech ETF by 72,900.0% in the 4th quarter. Huntington National Bank now owns 730 shares of the exchange traded fund’s stock worth $89,000 after purchasing an additional 729 shares in the last quarter. IPG Investment Advisors LLC acquired a new stake in SPDR S&P Biotech ETF in the 4th quarter worth approximately $202,000. Waystone Advisors LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $363,000. Finally, Steel Grove Capital Advisors LLC purchased a new stake in SPDR S&P Biotech ETF during the 4th quarter worth approximately $277,000.
SPDR S&P Biotech ETF Trading Down 2.2%
Shares of SPDR S&P Biotech ETF stock opened at $133.62 on Tuesday. The firm’s 50 day simple moving average is $131.22 and its two-hundred day simple moving average is $126.19. The firm has a market capitalization of $8.52 billion, a price-to-earnings ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 12-month low of $79.49 and a 12-month high of $139.19.
About SPDR S&P Biotech ETF
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
